DISCLAIMER: This is a working document provided by the Centers for Disease Control and Prevention (CDC) 

technical support contractor, SC&A for use in discussions with the National Institute for Occupational Safety and 

Health (NIOSH) and the Advisory Board on Radiation and Worker Health (ABRWH), including its Working Groups or 

Subcommittees. Documents produced by SC&A, such as memorandum, white paper, draft or working documents are 

not final NIOSH or ABRWH products or positions, unless specifically marked as such. This document prepared by 

SC&A represents its preliminary evaluation on technical issues.

NOTICE: This document has been reviewed to identify and redact any information that is protected by the 

Privacy Act 5 U.S.C. § 552a and has been cleared for distribution. 

Relevant Supplemental Topics: SCPR-Approved Document Reviews 

with Comments

Meeting of the Subcommittee for Procedure Reviews

February 15, 2022

Table 1. Documents reviewed and closed by the SCPR

Finding 

date

Document & 

revision number, 

date

Document title Total

findings

SCPR 

closed 

date

Comments

ABRWH 

closed 

date

6/8/2006 ORAUT-OTIB-0014, 

rev. 00, 

June 22, 2004

Technical 

Information 

Bulletin – 

Assignment of 

Environmental 

Internal Doses for 

Employees Not 

Exposed to 

Airborne 

Radionuclides in 

the Workplace

1 4/11/2012 Current 

document

Not yet

presented 

to Board

12/8/2008 ORAUT-OTIB-0066, 

rev. 01, Oct. 15, 

2020

Calculation of 

Dose from Intakes 

of Special Tritium 

Compounds

4 11/3/2021 Current 

document

Not yet 

presented 

to Board

10/9/2018 ORAUT-RPRT-0086, 

rev. 00, 

Sept. 18, 2017

Internal Dosimetry 

Coworker Data 

Completeness 

Test

3 2/13/2019 Current 

document

Not yet 

presented 

to Board

1/26/2019 DCAS-PER-080, 

rev. 0, 

August 30, 2017

General Steel 

Industries

1 2/13/2019 At least one 

external or 

internal 

pathway dose 

increased 

during the 

operational 

period

Not yet 

presented 

to Board

1/3/2017 DCAS-PER-057, 

rev. 0, 

March 11, 2015

General Steel 

Industries

11 (from 

Subtask 4 

review)

11/3/2021 Dose 

increases for 

operation and 

residual 

periods

Not yet 

presented 

to Board
SC&A, Inc.

Supplemental Topics, page 2 February 15, 2022

NOTICE: This document has been reviewed to identify and redact any information that is protected by the 

Privacy Act 5 U.S.C. § 552a and has been cleared for distribution. 

Finding 

date

Document & 

revision number, 

date

Document title Total

findings

SCPR 

closed 

date

Comments

ABRWH 

closed 

date

7/17/2017 DCAS-PER-063, 

rev. 0,

June 15, 2015

Aluminum 

Company of 

America – 

Pennsylvania 

(ALCOA-PN)

0 11/3/2021 External and 

internal doses 

increased 

during 

operational 

period

Not yet 

presented 

to Board

6/15/2017 DCAS-PER-065, 

rev. 0, 

Nov. 30, 2015

Anaconda 

Program 

Evaluation Report, 

Rev. 0

1 11/2/2021 External dose 

increased for 

all job 

categories

Not yet 

presented 

to Board

1/3/2017 DCAS-PER-064, 

rev. 0, Nov. 16, 2015

DuPont Deep 

Water Works

0 10/31/2018 Ingestion and 

external dose 

increased

Not yet 

presented 

to Board

2/18/2015 DCAS-PER-042, 

rev. 0, Nov. 16, 2012

Linde Ceramics 

Plant TBD 

Revision

3 5/16/2016 Not suitable 

for matrix

Not yet 

presented 

to Board

1/10/2017 DCAS-PER-055, 

rev. 0, 

Sept. 12, 2014

TBD-6000 

Revision

2 10/31/2018 Not suitable 

for matrix

Not yet 

presented 

to Board

6/8/2006 NIOSH-OVER-0002, 

rev. 00, 

Oct. 26, 2012

Workplace 

Ingestion

1 2/5/2013 Not suitable 

for matrix

Not yet 

presented 

to Board

11/23/2014 OCAS-PER-009, 

rev. 0, March 8, 2007

Target Organs for 

Lymphoma

6 2/18/2015 Not suitable 

for matrix

Not yet 

presented 

to Board

11/13/2013 OCAS-PER-020, 

rev. 0, July 31, 2007 

Blockson TBD 

Revision

6 11/25/2014 Not suitable 

for matrix

Not yet 

presented 

to Board

6/8/2006 OCAS-PR-007, 

rev. 02, 

April 18, 2005

Dose 

Reconstruction 

Review

9 10/14/2008 Not suitable 

for matrix

Not yet 

presented 

to Board

6/8/2006 ORAUT-OTIB-0011, 

rev. 00, 

June 29, 2004

Technical 

Information 

Bulletin: Tritium 

Calculated and 

Missed Dose 

Estimates

2 10/2/2007 Not suitable 

for matrix

Not yet 

presented 

to Board

6/8/2006 ORAUT-OTIB-0019, 

rev. 01, Oct. 7, 2005 

Analysis of 

Coworker 

Bioassay Data for 

Internal Dose 

Assignment

1 10/14/2008 Not suitable 

for matrix

Not yet 

presented 

to Board

11/5/2013 ORAUT-OTIB-0054, 

rev. 01, 

June 13, 2013

Fission and 

Activation Product 

Assignment for 

Internal DoseRelated Gross 

Beta and Gross 

Gamma Analyses

36 4/28/2015 Not suitable 

for matrix

Not yet 

presented 

to Board
SC&A, Inc.

Supplemental Topics, page 3 February 15, 2022

NOTICE: This document has been reviewed to identify and redact any information that is protected by the 

Privacy Act 5 U.S.C. § 552a and has been cleared for distribution. 

Finding 

date

Document & 

revision number, 

date

Document title Total

findings

SCPR 

closed 

date

Comments

ABRWH 

closed 

date

10/29/2007 ORAUT-OTIB-0057, 

rev. 00, 

May 15, 2006

External Radiation 

Dose Estimates for 

Individuals Near 

the 1958 Criticality 

Accident at the 

Oak Ridge Y-12 

Plant

3 8/8/2011 Not suitable 

for matrix

Not yet 

presented 

to Board

10/31/2012 ORAUT-PROC-0044, 

rev. 00, Oct. 7, 2005 

Special Exposure 

Cohort

10 11/20/2017 Not suitable 

for matrix

Not yet 

presented 

to Board

1/17/2005 ORAUT-PROC-0090, 

rev. 00, 

June 21, 2005

Computer Assisted 

Telephone 

Interview Process

29 4/28/2015 Not suitable 

for matrix

Not yet 

presented 

to Board

9/20/2007 ORAUT-PROC-0092, 

rev. 00, 

August 17, 2005

Close-Out 

Interview Process

9 4/28/2015 Not suitable 

for matrix

Not yet 

presented 

to Board

10/9/2018 DCAS-PER-049, 

rev. 0, 

August 5, 2016

Paducah Gaseous 

Diffusion Plant

0 10/31/2018 Occupational 

medical, 

external 

environmental, 

external 

neutron dose 

increased

Not yet 

presented 

to Board

10/9/2018 DCAS-PER-081, 

rev. 0, 

October 17, 2017

Hooker 

Electrochemical 

2 2/13/2019 Presented at 

12/8/2021 

Board meeting

12/8/2021

6/8/2006 ORAUT-OTIB-0025, 

rev. 00, April 5, 2005 

Estimation of 

Radium-226 

Activity in the Body 

from Breath 

Radon-222 

Measurements

1 12/11/2007 Presented at 

12/8/2021 

Board meeting

12/8/2021

10/29/2007 ORAUT-OTIB-0032, 

rev. 00 PC-1, 

Nov. 7, 2006

External Coworker 

Dosimetry Data for 

the Savannah 

River Site

2 5/16/2016 Presented at 

12/8/2021 

Board meeting

12/8/2021

6/8/2006 ORAUT-OTIB-0033, 

rev. 00, 

April 20, 2005

Application of 

Internal Doses 

Based on 

ClaimantFavorable 

Assumptions for 

Processing as 

Best Estimates

1 10/31/2018 Presented at 

12/8/2021 

Board meeting

12/8/2021

6/8/2006 ORAUT-PROC-0022, 

rev. 00, 

March 15, 2005

Supplemental 

Requests for DOE 

Information

2 11/20/2017 Presented at 

12/8/2021 

Board meeting

12/8/2021
SC&A, Inc.

Supplemental Topics, page 4 February 15, 2022

NOTICE: This document has been reviewed to identify and redact any information that is protected by the 

Privacy Act 5 U.S.C. § 552a and has been cleared for distribution. 

Finding 

date

Document & 

revision number, 

date

Document title Total

findings

SCPR 

closed 

date

Comments

ABRWH 

closed 

date

5/16/2016 OCAS-PER-008, 

rev. 0, April 12, 2007 

Modification of 

NIOSH-IREP Lung 

Cancer Risk 

Model: Effect of 

“Combined” Lung 

Model on 

Non-compensable 

Lung Cancer 

Claims

2 6/8/2016 Relevant 

document 

even though 

IREP updated

Not yet 

presented 

to Board

6/8/2006 ORAUT-OTIB-0023, 

rev. 00, 

March 7, 2005

Assignment of 

Missed Neutron 

Doses Based on 

Dosimeter 

Records

8 6/24/2008 Relevant 

document 

even though 

OTIB revised

Not yet 

presented 

to Board

10/29/2007 OCAS-PER-006, 

rev. 0, 

Sept. 15, 2006

External Dosimetry 

Target Organ for 

Prostate Cancer

1 12/9/2008 Relevant 

document 

even though 

OTIB-0005 

revised

Not yet 

presented 

to Board

10/31/2017 DCAS-RPT-005, 

rev. 01, 

August 17, 2018

Alternative 

Dissolution Models 

for Insoluble 

Pu-238

2 2/18/2021 Relevant 

document 

even though 

RPT revised

Not yet 

presented 

to Board

2/17/2015 DCAS-PER-047, 

rev. 0, 

March 26, 2014

Grand Junction 

Operations Office

4 2/18/2021 Relevant 

document 

even though 

TBD revised

Not yet 

presented 

to Board

12/29/2016 DCAS-PER-066, 

rev. 0, Nov. 30, 2015

Huntington Pilot 

Plant

1 10/31/2018 Relevant 

document 

even though 

TBD revised

Not yet 

presented 

to Board

10/29/2007 OCAS-PER-003, 

rev. 0, 

January 28, 2005

Evaluation of the 

Effect of Adding 

Ingestion Intakes 

to Bethlehem Steel 

Cases

4 5/16/2016 Relevant 

document 

even though 

TBD revised

Not yet 

presented 

to Board

4/16/2013 OCAS-PER-005, 

rev. 0, June 9, 2006

Misinterpreted 

Application of the 

External Dose 

Factor for Hanford 

Dose 

Reconstructions

1 5/16/2016 Relevant 

document 

even though 

TBD revised

Not yet 

presented 

to Board

12/5/2013 OCAS-PER-025, 

rev. 0, 

Sept. 28, 2007

Huntington Pilot 

Plant TBD 

Revision

4 2/13/2014 Relevant 

document 

even though 

TBD revised

Not yet 

presented 

to Board

10/29/2018 DCAS-PER-076, 

rev. 0, 

February 15, 2017

Aliquippa Forge 

TBD 

0 2/13/2019 Residual 

period internal 

and external 

doses 

increased

Not yet 

presented 

to Board
SC&A, Inc.

Supplemental Topics, page 5 February 15, 2022

NOTICE: This document has been reviewed to identify and redact any information that is protected by the 

Privacy Act 5 U.S.C. § 552a and has been cleared for distribution. 

Finding 

date

Document & 

revision number, 

date

Document title Total

findings

SCPR 

closed 

date

Comments

ABRWH 

closed 

date

2/17/2015 DCAS-PER-043, 

rev. 0, June 7, 2013

Internal Dosimetry 

Organ, External 

Dosimetry Organ, 

and IREP Model 

Selection by ICD-9 

Code Revision

3 4/28/2015 Revision: 

OTIB-0005 

rev. 06 

(Sept. 2019 

for ICD-10)

Not yet 

presented 

to Board

11/25/2014 DCAS-PER-038, 

rev. 0, July 24, 2012 

Hooker 

Electrochemical 

TBD Revisions

0 11/25/2014 SC&A 

reviewed 

revised TBD 

9/13/2016

Not yet 

presented 

to Board

2/17/2015 DCAS-PER-033, 

rev. 0, 

December 9, 2011

Reduction Pilot 

Plant TBD 

Revision

0 2/17/2015 TBD will be 

revised due to 

SEC ER

Not yet 

presented 

to Board

1/17/2005 ORAUT-PROC-0002, 

rev. 00, 

August 14, 2003

Use of Integrated 

Modules for 

Bioassay Analysis 

(IMBA)

3 7/26/2006 Unsure about 

current status

Not yet 

presented 

to Board

4/25/2013 ORAUT-PROC-0031, 

rev. 00 PC-2, 

Nov. 14, 2011

Site Profile and 

Technical Basis 

Document 

Development

5 7/9/2013 Unsure about 

current status

Not yet 

presented 

to Board

6/8/2006 ORAUT-PROC-0077, 

rev. 00, 

March 28, 2005

Dose 

Reconstruction 

Error Tracking and 

Reporting

3 11/7/2007 Unsure about 

current status

Not yet 

presented 

to Board

1/26/2019 DCAS-PER-077, 

rev. 0, 

February 28, 2017

Simonds Saw and 

Steel TBD

0 2/13/2019 Uranium 

intakes 

increased

Not yet 

presented 

to Board

Note. ABRWH = Advisory Board on Radiation and Worker Health; ER = evaluation report; ICD = International 

Classification of Diseases; IMBA = Integrated Modules for Bioassay Analysis; IREP = Interactive 

RadioEpidemiological Program; SCPR = Subcommittee for Procedure Reviews; SEC = Special Exposure Cohort; 

TBD = technical basis document.